Home
Toggle navigation
Ablynx
Our Company
Overview
Strategy
Technology & innovation
Understanding Nanobodies
Nanobodies Competitive Features
Intellectual Property
Publications
R&D portfolio
Overview
Clinical Programmes
Caplacizumab
ALX-0171
ALX-0761/M1095
Ozoralizumab
ALX-0141
Clinical Trials
Patients
Investigator
Patient Resources
Early Access to IMPs
Investors
Sanofi acquires Ablynx
Corporate Governance
Principles, codes and guidelines
Partnerships
Overview
Current Partnerships
Contact
News & events
Overview
Press Releases
Events & Presentations
Image Gallery
Careers
Working at Ablynx
Job Opportunities
Contact
Contact Form
Press Releases
Ablynx
>
News & events
>
Press Releases
No publications currently exist in this section.
Latest press releases:
2019
Archive:
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007